Express News | Hong Kong stocks in the technology sector have once again surged, with the Hang Seng Biotechnology ETF (159615), China Southern HSCEI ETF (159954), and Hong Kong Technology ETF (159747) aiding in the layout of sector leaders.

BreakingsMar 14 13:47

The 2025 action plan to stabilize foreign investment specifically mentions the pharmaceutical sector, with Innovative Drugs rising against the trend.

On February 20, according to Gelonghui, today's A-shares in Hk had a slight pullback, with the Biomedical Sector initially rising. TIGERMED increased by over 8%, Joinn Laboratories and PHARMARON rose by over 6%, while WUXI APPTEC and WUXI BIO also saw gains, with Gede Pharmaceutical up more than 30%. In terms of news, the "2025 Action Plan for Stabilizing Foreign Investment" proposed to study and improve the open policies in the pharmaceutical field, facilitate the accelerated market entry of Innovative Drugs, optimize the bulk procurement of pharmaceuticals, further increase the predictability of medical instruments product procurement, and proposed the expansion of pilot programs in fields such as healthcare to promote the orderly opening of the Biomedical sector. Additionally, Gede Pharmaceutical's small molecule oral GLP-1R agonist.

Gelonghui FinanceFeb 20 10:12

China's top private equity firms reveal their "US stock report card": Shareholding in Alibaba and PDD Holdings, while Chinese concept stocks still account for half of the market.

① As most Institutions reveal their Q4 Hold Positions data (Form 13F) for US stocks, domestic investors once again focus on the overseas investment trends of Chinese private equity firms such as Hillhouse, Gao Yi, and Jinglin. ② Overall, Chinese private equity firms like Hillhouse, Gao Yi, and Jinglin reduced their holdings in some Chinese concept stocks like Alibaba and PDD Holdings in the fourth quarter of US stocks, but Chinese concept stocks still account for a large portion of their Hold Positions.

cls.cnFeb 17 20:54

etf midday review | Cross-border etfs are up, with the S&P biotechnology etf rising over 2%.

On December 9, Gelonghui reported that the three major indices of A-shares collectively adjusted in the morning session. By noon, the Shanghai Composite Index dropped by 0.40%, the Shenzhen Component Index fell by 0.94%, the chinext price index declined by 1.40%, and the North Exchange 50 index decreased by 3.05%. The total market turnover for half a day was 1107.1 billion yuan, a decrease of 59.8 billion yuan compared to the previous day. More than 3,800 stocks in the all market fell. In terms of sectors, PEEK materials, humanoid robots, CRO concepts, and the chemical sector had the largest gains; meanwhile, the real estate, movie theater line, and semiconductors sectors experienced the largest declines. Regarding ETFs, cross-border ETFs strengthened, with the Harvest Fund S&P Biotech ETF and Huasan Fund France.

Gelonghui FinanceDec 9, 2024 11:39

US stocks closed | The three major indices rose together, the Dow and S&P continued to hit historical highs; most large technology stocks rose, nvidia rose more than 2%, Tesla soared more than 38% in the month, the best performance in nearly two years

US stocks posted weekly gains of over 1%, with the Dow rising by 7.5% in November and the S&P up 5.7%, both achieving the best performance of the year. The Nasdaq accumulated an increase of over 6%, small-cap indices rose by nearly 11%, the chip index rose by 1.5% on Friday but declined monthly, and Tesla saw a monthly increase of over 38%, its best performance in nearly two years.

Futu NewsNov 30, 2024 09:27

Unmissable investment strategy! The Federal Reserve officially enters a new era of interest rate cuts, these 6 industries have the most profitable potential.

Prepare yourself for the interest rate cut cycle.

Futu NewsSep 19, 2024 08:50